ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 11, 2016, at 2:20 p.m. Pacific Time in Las Vegas. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.ac


VIDEO: Connectomics used to aggregate data on effects of low vision on visual pathways

SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, James Weiland, MD, of the USC Roski Eye Institute, describes connectomics in low vision, a new area of research that incorporates detailed study of structure and function of the retina and of the brain to determine the effect of low vision and blindness on visual pathways.